Method of determining toxicity of an immunomodulatory drug for use in humans preliminary class
US11959926B2 · kind B2 · utility
1Cited by
1References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 26, 2023 |
| Grant date | Apr 16, 2024 |
| Priority date | — |
| Expiry date | Jun 26, 2043 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/24
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Humanized mouse models and methods are provided for determining whether administration of an immunomodulatory drug likely elicits a severe cytokine release syndrome in a human. Humanized mouse models and methods are also provided for determining the immunotoxicity in a human of a drug candidate or of drug combinations.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.